 ROCKVILLE, Md., Jan. 26, 2021 PRNewswire -- RegeneRx Biopharmaceuticals, Inc. OTCQB: RGRX the Company or RegeneRx, a clinical-stage drug development company focused on tissue protection, repair and regeneration, is addressing rumors in the market regarding its ARISE-3 phase 3... 